Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA vaccine
Biotech
Scancell enjoys stock bounce on back of cancer vaccine data
It’s been a good week for Scancell, as investors appeared to seized on early data from a phase 2 cancer vaccine trial to send its stock up 20%.
James Waldron
Sep 19, 2023 10:55am
Inovio's endpoint switcheroo backfires as phase 3 fails new test
Mar 2, 2023 5:20am
Inovio drops Lassa, MERS vaccines as clinical data fall short
Nov 18, 2022 5:25am
Inovio CEO departs, leaving Jacqueline Shea in charge
May 11, 2022 10:00am
Inovio pauses COVID-19 vaccine trial, seeks endpoint switch
Mar 2, 2022 7:40am
DNA vaccine spurs antibodies against Parkinson's target in mice
Jan 18, 2022 8:50am
